{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:14:57Z","timestamp":1761718497431,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.freeradbiomed.2016.07.024","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T09:18:05Z","timestamp":1469524685000},"page":"616-617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Retinoids and PPAR agonists: Promising partners in neurodegenerative diseases?"],"prefix":"10.1016","volume":"97","author":[{"given":"Javier","family":"Riancho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.freeradbiomed.2016.07.024_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2016.06.023","article-title":"PPARgamma as a therapeutic target to rescue mitochondrial function in neurological disease","author":"Corona","year":"2016","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.07.024_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cell.2014.03.012","article-title":"Nuclear receptors, RXR, and the big bang","volume":"157","author":"Evans","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2016.07.024_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jns.2015.11.058","article-title":"Retinoids and motor neuron disease: potential role in amyotrophic lateral sclerosis","volume":"360","author":"Riancho","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"6075","key":"10.1016\/j.freeradbiomed.2016.07.024_bib4","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models","volume":"335","author":"Cramer","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.07.024_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00415-015-8004-0","article-title":"Relaunching an old drug: the potential role of bexarotene in neurodegenerative diseases","volume":"263","author":"Riancho","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.freeradbiomed.2016.07.024_bib6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fncel.2015.00250","article-title":"Neuroprotective effect of bexarotene in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"9","author":"Riancho","year":"2015","journal-title":"Front. Cell Neurosci."},{"issue":"8","key":"10.1016\/j.freeradbiomed.2016.07.024_bib7","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1158\/1078-0432.CCR-09-2499","article-title":"Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma","volume":"16","author":"He","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.07.024_bib8","first-page":"1083","article-title":"Enhanced effects of PPARgamma ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells","volume":"21","author":"Papi","year":"2009","journal-title":"Oncol. Rep."}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584916303446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584916303446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:39:55Z","timestamp":1760204395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584916303446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":8,"alternative-id":["S0891584916303446"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.07.024","relation":{},"ISSN":["0891-5849"],"issn-type":[{"type":"print","value":"0891-5849"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinoids and PPAR agonists: Promising partners in neurodegenerative diseases?","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}